Vergleich

LFNG Polyclonal Antibody

ArtNr E-AB-53116-60
Hersteller Elabscience
Menge 60uL
Kategorie
Typ Antibody Polyclonal
Applikationen WB, IHC, ELISA
Specific against Human, Mouse, Rat
Host Rabbit
Isotype IgG
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias 3-N-acetylglucosaminyltransferase lunatic fringe, Beta-1, Beta-13-N-acetylglucosaminyltransferase lunatic fringe, lfng, LFNG, O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase, SCDO3
Similar products LFNG, Beta-1, O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase, lfng, SCDO3, 3-N-acetylglucosaminyltransferase lunatic fringe, Beta-13-N-acetylglucosaminyltransferase lunatic fringe
Lieferbar
Research Areas
Developmental Biology, Neuroscience, Stem Cells
Synonyms
3-N-acetylglucosaminyltransferase lunatic fringe, Beta-1, Beta-13-N-acetylglucosaminyltransferase lunatic fringe, lfng, LFNG, O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase, SCDO3
Swissprot
Q8NES3
Background
This gene is a member of the fringe gene family which also includes radical and manic fringe genes. They all encode evolutionarily conserved glycosyltransferases that act in the Notch signaling pathway to define boundaries during embryonic development. While their genomic structure is distinct from other glycosyltransferases, fringe proteins have a fucose-specific beta-1, 3-N-acetylglucosaminyltransferase activity that leads to elongation of O-linked fucose residues on Notch, which alters Notch signaling. This gene product is predicted to be a single-pass type II Golgi membrane protein but it may also be secreted and proteolytically processed like the related proteins in mouse and Drosophila (PMID: 9187150). Mutations in this gene have been associated with autosomal recessive spondylocostal dysostosis 3. Multiple transcript variants encoding different isoforms have been found for this gene.
Concentration
1.08 mg/mL
Storage
Store at -20C. Avoid freeze / thaw cycles.
Immunogen
Fusion protein of human LFNG
Buffer
PBS with 0.05% NaN3 and 40% Glycerol, pH7.4
Purification Method
Antigen affinity purification
Dilution
WB 1:500-1:2000, IHC 1:50-1:200, ELISA 1:5000-1:10000
Conjugation
Unconjugated
Calculated MW
42 kDa
Observed MW
Refer to figures
Gene Accession
BC014851

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 60uL
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen